New hope for obesity patients as FDA approves Saxenda

December 29, 2014 3:48 PM

15 0

After promising clinical trials, the Food and Drug Administration (FDA) has approved a drug called Saxenda for chronic weight management that will be available by prescription to overweight and obese adults.

Intended to accompany a diet and exercise plan, Saxenda is a once-daily injection of an imitation of the hormone GLP-1 (glucagon-like peptide) that tells the brain when the stomach is full.

Read more

To category page